MedPath

Hyperglycaemia in Neonates Trial:Computer determined insulin dosage in the management of neonatal hyperglycaemia

Not Applicable
Recruiting
Conditions
eonatal Hyperglycaemia
Premature birth
Neonatal Hyperglycaemia
Reproductive Health and Childbirth - Complications of newborn
Registration Number
ACTRN12614000492651
Lead Sponsor
niversity of Auckland; Department of Paediatrics: Child and Youth Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
138
Inclusion Criteria

Preterm babies < 30 weeks’ gestation or <1,500 g at birth who develop hyperglycaemia (2 consecutive blood glucose concentrations greater than or equal to 10 mmol / L at least 4 h apart) whose parents give written informed consent.

Exclusion Criteria

Congenital abnormalities likely to affect life expectancy or neurological development; previous insulin treatment; judged to be at risk of imminent death.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hypoglycaemia (any blood glucose concentration < 2.6 mmol / L), detected by intermittent blood glucose monitoring.[While receiving an intravenous insulin infusion]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath